(Medical Xpress)—Pulmonary surfactants are phospholipoproteins (surface-active lipoprotein complexes) that reduces alveolar surface tension through an air-water hydrophilic/hydrophobic interface. Pulmonary, or lung, surfactants ...
(Medical Xpress)—Vasculogenesis – the process of blood vessel formation through a de novo production of endothelial cells (ECs, or those forming a thin layer lining the interior surface of blood and lymphatic vessels) ...
(Medical Xpress)—In the battle against aging and age-related neurological diseases such as Parkinson's and Alzheimer's, a key factor has long appeared to be the toxicity of proteins which tend to aggregate. Recently, scientists ...
(Medical Xpress) -- On the complex road to eradicating cancer, controlling or preventing metastatic growth initiated by primary tumors is high on the to-do list. A key area of such research is the development of therapies ...
(Medical Xpress) -- Of the world’s leading causes of death, stroke ranks second – and occurring 8 out of 10 times is ischemic stroke: reduced blood supply to the brain creates a shortage of oxygen, glucose and other ...
Researchers at the Scripps Research Institute, Florida, have developed a new method to counteract α-synuclein protein levels by targeting the mRNA that forms them. The strategy unlocks many research doors with potential ...
Great news for those who lost some or all of their sense of smell or taste due to COVID-19: The effect, while persistent, does not appear to be permanent. A study led by the University of Trieste, Italy, has found that despite ...
A meta-analysis by the Brigham and Women's Hospital, Boston, has found a possible role for nutraceutical supplements in treating acne, one that will require better research practices to reveal their effectiveness.
A clinical trial led by Yuejin Yang of the Chinese Academy of Medical Sciences and Peking Union Medical College, China, has concluded that a Chinese traditional medicine compound, Tongxinluo, reduced major adverse cardiac ...
Research led by the Dana Farber Cancer Institute, Massachusetts, performed a secondary analysis of the Dana-Farber Cancer Institute 05-043 trial. In the paper, "Risk of Short-Term Prostate-Specific Antigen Recurrence and ...
